Regression to the Mean: Implications for Clinical Trials of Psychotropic Agents in Dementia

E-ISSN： 1875-5828|1|4|323-328

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.1, Iss.4, 2004-11, pp. : 323-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors

By Erkinjuntti Timo Román Gustavo Gauthier Serge

Neurological Research, Vol. 26, Iss. 5, 2004-07 ,pp. : 603-605

Maney Publishing

Access to resources Recommend Favorite

Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials

By Anthony Karen

Brain, Vol. 134, Iss. 12, 2011-12 ,pp. : 3544-3556

Oxford University Press

Access to resources Recommend Favorite

The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management

World Psychiatry, Vol. 17, Iss. 1, 2018-02 ,pp. : 3-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of a placebo in clinical trials

By Emilien G. Maloteaux J. Seghers A. Charles G.

European Psychiatry, Vol. 13, Iss. 5, 1998-08 ,pp. : 254-263

Elsevier

Access to resources Recommend Favorite

Seizure Measurement in Clinical Trials

By Cramer J.A.

Journal of Epilepsy, Vol. 11, Iss. 5, 1998-09 ,pp. : 256-260

Elsevier

Access to resources Recommend Favorite